Coherus BioSciences (CHRS) Stock Chart & Stock Price History $1.07 -0.03 (-2.73%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.10 +0.02 (+2.34%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Coherus BioSciences Stock Price Performance 5 Day Performance-9.32%1 Month Performance-18.32%3 Month Performance-1.83%6 Month Performance-18.94%Year-To-Date Performance-22.46%1 Year Performance-56.68% Receive CHRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Coherus BioSciences and its competitors with MarketBeat's FREE daily newsletter. Email Address CHRS Stock Chart for Saturday, February, 22, 2025 CHRS Chart by TradingView Coherus BioSciences Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$1.10$1.07-2.73%$1.14$1.071.55 million shs$124.00 million02/20/2025$1.10$1.10$1.16$1.081.51 million shs$127.48 million02/19/2025$1.12$1.10-1.79%$1.15$1.061.90 million shs$127.48 million02/18/2025$1.18$1.12-5.08%$1.20$1.111.19 million shs$129.80 million02/17/2025$1.18$1.18$1.21$1.15946,292 shs$136.75 million02/14/2025$1.16$1.18+1.72%$1.21$1.15946,292 shs$136.75 million02/13/2025$1.12$1.16+3.57%$1.16$1.091.04 million shs$134.43 million02/12/2025$1.11$1.12+0.90%$1.14$1.081.22 million shs$129.80 million02/11/2025$1.17$1.11-5.13%$1.19$1.111.01 million shs$128.64 million02/10/2025$1.12$1.17+4.46%$1.18$1.121.09 million shs$135.59 million Get the Latest News and Ratings for CHRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Coherus BioSciences and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$1.13$1.12-0.88%$1.17$1.12928,208 shs$129.80 million02/06/2025$1.20$1.13-5.83%$1.21$1.131.25 million shs$130.96 million02/05/2025$1.16$1.20+3.45%$1.24$1.17982,363 shs$139.07 million02/04/2025$1.11$1.16+4.50%$1.23$1.111.84 million shs$134.43 million02/03/2025$1.18$1.11-5.93%$1.21$1.111.70 million shs$128.64 million01/31/2025$1.35$1.18-12.59%$1.38$1.153.32 million shs$136.75 million01/30/2025$1.22$1.35+10.66%$1.39$1.232.88 million shs$155.53 million01/29/2025$1.11$1.22+9.91%$1.25$1.103.22 million shs$140.56 million01/28/2025$1.16$1.11-4.31%$1.19$1.034.90 million shs$127.88 million01/27/2025$1.24$1.16-6.45%$1.29$1.134.01 million shs$133.64 million01/24/2025$1.28$1.24-3.13%$1.38$1.213.21 million shs$142.86 million01/23/2025$1.31$1.28-2.29%$1.36$1.244.22 million shs$147.47 million01/22/2025$1.32$1.31-0.76%$1.45$1.292.89 million shs$150.93 million01/21/2025$1.39$1.32-5.04%$1.43$1.312.12 million shs$152.08 million Related Companies Xeris Biopharma Stock Price Chart Compass Therapeutics Stock Price Chart MeiraGTx Stock Price Chart Humacyte Stock Price Chart Autolus Therapeutics Stock Price Chart Precigen Stock Price Chart Tectonic Therapeutic Stock Price Chart Alpha Teknova Stock Price Chart SNDL Stock Price Chart Entrada Therapeutics Stock Price Chart Receive CHRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Coherus BioSciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CHRS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coherus BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coherus BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
